Skip to main content
The Texas Heart Institute Journal logoLink to The Texas Heart Institute Journal
. 2006;33(4):424–426.

A Proposed Alternative Mechanism of Action for Transmyocardial Revascularization Prefaced by a Review of the Accepted Explanations

Marcelo Cardarelli 1
PMCID: PMC1764952  PMID: 17215963

Abstract

Laser transmyocardial revascularization, a procedure originally intended to simulate the perfusion mechanism of the reptilian heart, has evolved into an effective but poorly understood treatment for angina when traditional revascularization is not an option. Herein, we review the explanations that have been proposed over the years and suggest a new one. We hypothesize that the long-term mechanism of action of transmyocardial revascularization is the redistribution of stresses on the ventricular wall through the creation of fibrous transmyocardial scars, which penetrate the various layers of muscle that surround the left ventricular cavity. The stress redistribution of a load in an otherwise unchanged ventricular wall reduces the wall stress per unit of wall volume, which in turn decreases the workload for the hyperkinetic compensating areas. This reduces both oxygen demand and local metabolite production, lowering the level of angina.

Key words: Angina pectoris/surgery, cicatrix, coronary circulation, holmium, laser surgery, myocardial ischemia/surgery, myocardial revascularization/methods, yttrium

The law of unintended consequences may have played, in more ways than one, a major role in the success of laser transmyocardial revascularization (TMR). A procedure originally intended to simulate the perfusion mechanism1 of the reptilian heart has evolved into an effective, albeit poorly understood, treatment for angina when traditional revascularization is not an option.

Randomized trials of laser TMR have demonstrated a beneicial effect on the angina scores of patients who have undergone this treatment,2–5 yet the science behind the procedure and the true mechanism of action still elude us.

Currently Accepted Possible Mechanisms of Action

Placebo Effect

Volumes have already been written on placebo effect, both in general and in speciic regard to TMR. It is not the objective of this work to speculate further on well-explored topics.

Angiogenesis

The available evidence suggests that TMR-induced angiogenesis is likely to be a nonspeciic response of the myocardium to injury, because a laser-speciic angiogenesis response has not been identiied.8

Increased vascular density can be seen in the area immediately surrounding the channel remnants, but this neo-vascularity does not seem to extend appreciably beyond that area.9,10 Results of post-TMR perfusion scans are mixed. Out of 5 randomized clinical trials of TMR as sole therapy, only 1 shows improvement in perfusion by positron-emission tomographic scan, whereas the results of thallium scans are more favorable.3,4,11

New vasculature in the laser-treated area could explain part of the observed clinical improvement, but the vascularization of myocardial scar tissue (that is, after infarct) has very modest oxygen-delivery capacity.12 Still, it remains to be proved that these new vessels play an active role in improving oxygen delivery beyond the immediate area of the channel remnant.

The calculated volume of tissue with microscopically proven neo-vascularity after the creation of 40 channels9,10 would range between 17.4% and 31.5% of the treatable myocardium (depending on the number of channels, the sex of the patient, and the body surface). Even in the best-case scenario, blood-low improvement by any conventional means of revascularization to only 31.5% of the target territory would be considered a marginal result; therefore, angiogenesis is not likely the sole mechanism of action.

Sympathetic Obliteration

Pain as a relection of brain awareness of myocardial ischemia is dependent on afferent sympathetic ibers and ventricular receptors. Afferent iber denervation as a possible mechanism of angina relief is controversial and in any event would be temporary, given that heart re-innervation seems to occur within 6 months.13,14

Destruction of Ischemic Myocardium

The number of channels drilled on the free surface of the left ventricle (LV) during sole therapy with TMR is approximately 40. By knowing the area of damage (average, 4.5 mm2 for the holmium:YAG)6 and the thickness of the LV wall (average, 10 mm), we can calculate the volume of the myocardial cylinder destroyed during the procedure. The total volume of LV myocardium destroyed during a typical TMR procedure would amount to 1.8 cc3 of tissue, which, given its density, would be equivalent to only 2 grams of muscle. For the CO2-based laser, the volume of myocardial destruction would be about half that.

If we assume an average LV mass index of 76 ± 13 g/m2 in men and 66 ± 11 g/m2 in women7—one third of which (the septum) is beyond the reach of the laser—we are left with a mass of treatable ventricular myocardium of 80 to 113 g for men and 62.5 to 88 g for women. The volume of myocardial tissue destroyed by sole therapy with TMR, depending on the patient's sex and body mass, would be between 1.7% and 3.2% of the total treatable myocardium. This percentage of ischemic tissue destruction hardly explains angina relief.

An Alternative Hypothesis

Angina Relief in the Early Postoperative Period. Norepinephrine released by sympathetic activity is perhaps the most important mechanism that regulates myocardial activity. β-Blockers and norepinephrine-depleting drugs interfere with the myocardial response to sympathetic stimulation15 by successfully controlling the “overdrive” elicited when congestive heart failure is present.

Beek and coworkers,16 while looking for myocardial denervation, may have unintentionally happened upon an interesting inding. By using a test sensitive for the detection of myocardial postganglionic sympathetic dysfunction (123iodine-labeled metaiodobenzylguanidine cardiac scintigraphy),17,18 they may have found proof of efferent sympathetic denervation. This mechanism of action could provide immediate postoperative angina relief by offering the ultimate efferent surgical β-blockade, allowing for increments in cardiac output through a higher stroke volume rather than a higher heart rate and inotropic status—with an overall improved eficiency and a lower oxygen consumption.19

Angina Relief in the Late Postoperative Period. Akinesis and dyskinesis can be readily detected by visual inspection of angiograms or echocardiograms; however, the phenomenon of hypokinesis at the microscopic level cannot. Hearts with diffuse ischemia and preserved function must have, by definition, multiple microscopic areas of undetectable hypokinesis. These areas of hypokinesis are associated with hyperkinesis of other regions as a compensatory mechanism.15 Hyperkinesis increases oxygen demand and the accumulation of unwanted metabolic products in an area with limited blood flow and oxygen supply. Angina can only be made worse by this local compensatory mechanism.

Interfascicular Tension. Muscle fibers are arranged in different directions as they wrap to form the ventricular cavities. The most superficial fibers are disposed in an oblique fashion, the middle layers are circumferential, and the inner layers are arranged in a longitudinal mode.20 A simultaneous contraction of the fibers, distributed in different directions, creates extra tension in the fibrous and myocardial connections between the different layers.21 Furthermore, LV wall thickness increases 25% to 35% during systole, but the relative degree of sarcomere shortening cannot be the same across the ventricular wall. Geometrical considerations dictate that endocardial fibers must shorten relatively more than epicardial ones.15

Wall stress is defined as force per unit of cross-sectional area (in dynes/cm2) of muscle. The ventricular end-diastolic wall stress or resting tension determines the resting length of the sarcomeres,15 which in turn controls the amount of work that a sarcomere will be subjected to and therefore influences its oxygen demand.

During systole, the minor (transverse) axis of inner wall shortens by 20% to 25% while the major (apex–base) axis shortens by 9%; it is the shortening of the minor axis that accounts for 85% to 90% of the stroke volume.15 The most internal layers of muscle are the poorest oxygenated and must shorten the greatest distance, but the medial and outer layers are the most effective (more stroke per shortening) and generate the most stroke volume. Incidentally, this may provide a reasonable explanation of why some patients have preserved ventricular function, yet have scores that indicate severe angina.

A Side Note on Stress Distribution. The unquestionable icon of the Middle Ages was the Gothic cathedral. The use of flying buttresses to distribute and convey the collected pressures at pier intervals enabled the strain and stresses of the walls to be redistributed and ultimately transmitted to the ground.22 This innovative mechanism allowed medieval architects to design structures, in clear contrast with Romanesque churches, that supported greater loads and pressures despite thinner and taller walls—thus opening large spaces under the vault and permitting vast quantities of light to flood the nave.

Stress redistribution is also used in the construction of retaining walls, wherein the thickness of the wall needed to support the force and movement of retained soil can be reduced by the use of tieback tendons anchored to the bedrock. A good example of this is the “slurry” or diaphragm wall construction at the site of the World Trade Center.23

“Revascularization” or Re-Engineering? We could hypothesize that the long-term mechanism of action of TMR is the redistribution of stresses on the ventricular wall through the creation of ibrous transmyocardial scars, which penetrate the various layers of muscle that surround the left ventricular cavity. These well-vascularized scars or mini-tendons, evenly spaced throughout the thickness of the LV, would latch the different layers onto each other, reducing the interfascicular tension by acting as redistribution points. Wall stresses are now scattered to all layers from endocardium to epicardium, through the mini-tendons that act as buttresses or tiebacks.

Unlike architectural design, wherein redistribution of wall stress enables a thinner wall to support a heavier load, TMR does not alter the thickness of the ventricular wall. Nevertheless, the stress redistribution of a load in an otherwise unchanged ventricular wall reduces the wall stress per unit of wall volume, which in turn decreases the workload for the hyperkinetic compensating areas. This reduces both oxygen demand and local metabolite production, lowering the level of angina. Perhaps TMR should be understood in a new light, to mean transmyocardial re-engineering.

Footnotes

Address for reprints: Marcelo Cardarelli, MD, Division of Cardiac Surgery, University of Maryland Medical Center, 22 South Greene St., Suite N4W94, Baltimore, MD 21201 E-mail: mcard001@umaryland.edu

References

  • 1.Sen PK, Daulatram J, Kinare SG, Udwadia TE, Parulkar GB. Further studies in multiple transmyocardial acupuncture as a method of myocardial revascularization. Surgery 1968;64:861–70. [PubMed]
  • 2.Horvath KA. Results of prospective randomized controlled trials of transmyocardial laser revascularization. Heart Surg Forum 2002;5:33–40. [PubMed]
  • 3.Allen KB, Dowling RD, Schuch DR, Pfeffer TA, Marra S, Lefrak EA, et al. Adjunctive transmyocardial revascularization: ive-year follow-up of a prospective, randomized trial. Ann Thorac Surg 2004;78:458–65. [DOI] [PubMed]
  • 4.Frazier OH, March RJ, Horvath KA. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med 1999;341: 1021–8. [DOI] [PubMed]
  • 5.Allen KB, Dowling RD, Fudge TL, Schoettle GP, Selinger SL, Gangahar DM, et al. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med 1999;341:1029–36. [DOI] [PubMed]
  • 6.Fisher PE, Khomoto T, DeRosa CM, Spotnitz HM, Smith CR, Burkhoff D. Histologic analysis of transmyocardial channels: comparison of CO2 and holmium:YAG lasers. Ann Thorac Surg 1997;64:466–72. [DOI] [PubMed]
  • 7.Echo by Web: Left ventricular geometry. Available from: http://www.echobyweb.com/htm_level3_outofstructure/formulas&calculations/lv_geometry_eng.htm
  • 8.Bridges CR. Myocardial laser revascularization: the controversy and the data. Ann Thorac Surg 2000;69:655–62. [DOI] [PubMed]
  • 9.Kohmoto T, DeRosa CM, Yamamoto N, Fisher PE, Failey P, Smith CR, Burkhoff D. Evidence of vascular growth associated with laser treatment of normal canine myocardium. Ann Thorac Surg 1998;65:1360–7. [DOI] [PubMed]
  • 10.Mueller XM, Tevaearai HT, Genton CY, Chaubert P, von Segesser LK. Are there vascular density gradients along myocardial laser channels? Ann Thorac Surg 1999;68:125–30. [DOI] [PubMed]
  • 11.Lange RA, Hillis LD. Transmyocardial laser revascularization. N Engl J Med 1999;341:1075–6. [DOI] [PubMed]
  • 12.Sun Y, Kiani MF, Postlethwaite AE, Weber KT. Infarct scar as living tissue. Basic Res Cardiol 2002;97:343–7. [DOI] [PubMed]
  • 13.Minisi AJ, Topaz O, Quinn MS, Mohanty LB. Cardiac nociceptive relexes after transmyocardial laser revascularization: implications for the neural hypothesis of angina relief. J Thorac Cardiovasc Surg 2001;122:712–9. [DOI] [PubMed]
  • 14.Hughes GC, Baklanov DV, Biswas SS, Pippen AM, DeGrado TR, Coleman RE, et al. Regional cardiac sympathetic innervation early and late after transmyocardial laser revascularization. J Card Surg 2004;19:21–7. [DOI] [PubMed]
  • 15.Braunwald E, editor. Heart disease: a textbook of cardiovascular medicine. Philadelphia: WB Saunders; 1980. p. 429–78.
  • 16.Beek JF, van der Sloot JA, Huikeshoven M, Verberne HJ, van Eck-Smit BL, van der Meulen J, et al. Cardiac denervation after clinical transmyocardial laser revascularization: short-term and long-term iodine 123-labeled meta-iodobenzylguanide scintigraphic evidence. J Thorac Cardiovasc Surg 2004; 127:517–24. [DOI] [PubMed]
  • 17.Courbon F, Brefel-Courbon C, Thalamas C, Alibelli MJ, Berry I, Montastruc JL, et al. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease. Mov Disord 2003;18:890–7. [DOI] [PubMed]
  • 18.Psychari SN, Theodorakis GN, Koutelou M, Livanis EG, Kremastinos DT. Cardiac denervation after radiofrequency ablation of supraventricular tachycardias. Am J Cardiol 1998; 81:725–31. [DOI] [PubMed]
  • 19.Best CH, Taylor NB, West JB, editors. Best and Taylor's Physiological basis of medical practice. 11th ed. Baltimore: Williams & Wilkins; 1984. p. 245.
  • 20.Anderson RH, Becker AE, Allwork SP, editors. Cardiac anatomy: an integrated text and colour atlas. London: Gower Medical; 1980. p. 5.2–5.26.
  • 21.Rushmer RF, Blackmon JR. Cardiovascular dynamics. 3rd ed. Philadelphia: WB Saunders; 1970. p. 80.
  • 22.Fitchen J. The Construction of Gothic Cathedrals. Chicago: University of Chicago Press; 1961. p. 77.
  • 23.Tamaro GJ. World Trade Center “bathtub”: from genesis to armageddon. National Academy of Engineering. 2002;32(1). Available from: http://www.nae.edu/nae/bridgecom.nsf/weblinks/CGOZ-58NLJ9?OpenDocument

Articles from Texas Heart Institute Journal are provided here courtesy of Texas Heart Institute

RESOURCES